Fasudil compensates podocyte injury via CaMK4/Rho GTPases signal and actin cytoskeleton-dependent activation of YAP in MRL/lpr mice.


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 20 01 2023
revised: 15 03 2023
accepted: 11 04 2023
medline: 1 6 2023
pubmed: 25 4 2023
entrez: 24 04 2023
Statut: ppublish

Résumé

Deposition of immune complexes in the glomerulus leads to irreversible renal damage in lupus nephritis (LN), of which podocyte malfunction arises earlier. Fasudil, the only Rho GTPases inhibitor approved in clinical settings, possesses well-established renoprotective actions; yet, no studies addressed the amelioration derived from fasudil in LN. To clarify, we investigated whether fasudil exerted renal remission in lupus-prone mice. In this study, fasudil (20 mg/kg) was intraperitoneally administered to female MRL/lpr mice for 10 weeks. We report that fasudil administration swept antibodies (anti-dsDNA) and attenuated systemic inflammatory response in MRL/lpr mice, accompanied by preserving podocyte ultrastructure and averting immune complex deposition. Mechanistically, it repressed the expression of CaMK4 in glomerulopathy by preserving nephrin and synaptopodin expression. And fasudil further blocked cytoskeletal breakage in the Rho GTPases-dependent action. Further analyses showed that beneficial actions of fasudil on the podocytes required intra-nuclear YAP activation underlying actin dynamics. In addition, in vitro assays revealed that fasudil normalized the motile imbalance by suppressing intracellular calcium enrichment, thereby contributing to the resistance of apoptosis in podocytes. Altogether, our findings suggest that the precise manners of crosstalks between cytoskeletal assembly and YAP activation underlying the upstream CaMK4/Rho GTPases signal in podocytes is a reliable target for podocytopathies treatment, and fasudil might serve as a promising therapeutic agent to compensate for the podocyte injury in LN.

Identifiants

pubmed: 37094544
pii: S1567-5769(23)00520-9
doi: 10.1016/j.intimp.2023.110199
pii:
doi:

Substances chimiques

rho GTP-Binding Proteins EC 3.6.5.2
fasudil Q0CH43PGXS
Camk4 protein, mouse EC 2.7.11.17
Calcium-Calmodulin-Dependent Protein Kinase Type 4 EC 2.7.11.17

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110199

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Fengyuan Tian (F)

General Practice, The First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, PR China.

Shuo Huang (S)

First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, PR China.

Wangda Xu (W)

First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, PR China.

Guanqun Xie (G)

Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, PR China.

Yihong Gan (Y)

First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, PR China.

Fugang Huang (F)

First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, PR China.

Yongsheng Fan (Y)

Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, PR China. Electronic address: fyszjticm@163.com.

Jie Bao (J)

Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, PR China. Electronic address: sinkybj@126.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH